The end of Public Health England?
Media reports suggest that the body will be ‘scrapped and replaced’ to improve pandemic protection in the country
Read Moreby Selina McKee | Aug 17, 2020 | News | 0
Media reports suggest that the body will be ‘scrapped and replaced’ to improve pandemic protection in the country
Read Moreby Selina McKee | Jun 24, 2020 | News | 0
The multicentre programme will evaluate new tests in hospitals, GP surgeries and care homes around the country
Read Moreby Selina McKee | Jun 23, 2020 | News | 0
Over 14,000 GP staff, other essential key workers and university staff and their households will participate in the first phase of the trial
Read Moreby Selina McKee | May 22, 2020 | News | 0
10 million tests have so far have been secured in a ‘landmark deal’ with industry, including Roche Diagnostics and Abbott Labs
Read Moreby Selina McKee | May 19, 2020 | News | 0
A 19-page letter to the Prime Minister details ten key lessons the UK government should learn from its experience of handling the pandemic so far
Read Moreby Selina McKee | Apr 24, 2020 | News | 0
Employers and employees will be able to book a test directly for themselves or members of their household who are experiencing symptoms
Read Moreby Selina McKee | Apr 20, 2020 | News | 0
Frontline workers now eligible for testing will include the police, the fire service, frontline benefits workers and those working with vulnerable children and adults among others
Read Moreby Selina McKee | Apr 3, 2020 | News | 0
Testing for those with a medical need and the most critical workers is to rise to 25,000 a day by mid-to-late April
Read Moreby Selina McKee | Dec 2, 2016 | News | 0
The National Institute for Health and Care Excellence is recommending that HIV testing is routinely offered to millions of people living in areas with a high prevalence of the disease.
Read Moreby Selina McKee | Aug 18, 2016 | News | 0
The Association of the British Pharmaceutical Industry and the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) have announced a new collaboration to explore whether the safety testing of medicines can be refined.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
